Wednesday June 4, 1:00 pm ET
BOTHELL, Wash., June 4 /PRNewswire-FirstCall/ -- CellCyte Genetics Corporation's (CellCyte) (OTC BB: CCYG.OB) President and CEO, Gary A. Reys, will present at the 2008 San Francisco RedChip Small-Cap Investor Conference on Thursday, June 5, at 10:35 AM Pacific Daylight Time at the Palace Hotel in San Francisco. In addition, CellCyte will have a booth at the conference at which they will have a prototype demonstration of the Company's cell expansion bioreactor.
The presentation will be Web cast live with slides and archived for replay after the presentation at: http://www.redchip.com/visibility/conferencePages/SanFran2008/conferenceMain.a sp?page=webcast
About CellCyte Genetics
CellCyte Genetics Corporation is a biotechnology company engaged in the discovery, development and commercialization of stem cell enabling therapeutic products. CellCyte is developing products to allow more efficient delivery and increased retention of adult stem cells to diseased organs, such as the heart. The goal of these therapies is to increase the number of stem cells delivered to a damaged organ, thereby markedly increasing organ healing and functional restoration. The Company's lead product in development, CCG-TH30, is designed to send autologous bone marrow-derived (adult) stem cells to the heart of patients after a heart attack.
CellCyte Genetics 1725 220th Street SE Bothell Washington 98021
USA
For further information see: http://www.cellcyte.com.
Symbol: OTCBB - CCYG; Frankfurt/Berlin Symbol - LK6 WKN. No.: A0MLCV.
For Further Information, Contact:
RedChip Companies, Inc.
500 Winderley Place, Suite 100, Maitland, FL 32751,
(800) 733-2447,Fax: (407) 644-0758,
info@redchip.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment